IMC-A12 in Treating Patients With Advanced Liver Cancer

Summary

This phase II trial is studying how well IMC-A12 works in treating patients with advanced liver cancer. Monoclonal antibodies, such as IMC-A12, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them.

Timeline

Start

2008-03

Primary completion

2011-02

Completion

2011-02

Drugs

Indications